FIRST AMENDMENT TO COLLABORATION, LICENSE AND OPTION AGREEMENTLicense and Option Agreement • March 16th, 2021 • Curis Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 16th, 2021 Company IndustryThis First Amendment to Collaboration, License and Option Agreement (the “Amendment”) is entered into as of September 7, 2016 (the “Amendment Date”), by and between Aurigene Discovery Technologies Limited, a company organized under the laws of India, having an address of 39-40, KIADB Industrial Area, Phase II, Electronic City Hosur Road, Bangalore - 560100 Karnataka, India (“Aurigene”), and Curis, Inc., a corporation organized under the laws of Delaware, USA, having an address of 4 Maguire Road, Lexington, Massachusetts 02421-3112, USA (“Curis”).
FIRST AMENDMENT TO COLLABORATION, LICENSE AND OPTION AGREEMENTLicense and Option Agreement • November 3rd, 2016 • Curis Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 3rd, 2016 Company IndustryTHIS FIRST AMENDMENT TO COLLABORATION, LICENSE AND OPTION AGREEMENT (the “Amendment”) is entered into as of September 7, 2016 (the “Amendment Date”), by and between AURIGENE DISCOVERY TECHNOLOGIES LIMITED, a company organized under the laws of India, having an address of 39-40, KIADB Industrial Area, Phase II, Electronic City Hosur Road, Bangalore - 560100 Karnataka, India (“Aurigene”), and CURIS, INC., a corporation organized under the laws of Delaware, USA, having an address of 4 Maguire Road, Lexington, Massachusetts 02421-3112, USA (“Curis”).